A practical sourcing guide for baricitinib intermediates covering the synthesis route, three key fragments, palladium removal quality checks, CoA verification red flags, market context, and the approaching patent expiry window.
Suzetrigine (Journavx) is the first non-opioid pain drug approved in 27 years. This guide covers its synthesis route, four chiral centers, key intermediates, and what buyers need to check before sourcing.
A practical sourcing guide for resmetirom intermediates covering the synthesis pathway, key building blocks, quality checkpoints, old vs new manufacturing routes, and the MASH drug supply chain outlook.
Leading provider of high-quality APIs and intermediates. Contact us for innovative solutions and expert support.